Jon Stuart Ross
Corporate Secretary at CUBIC ENERGY INC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Calvin A. Wallen | M | 68 |
Venturis Therapeutics, Inc.
 Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 25 years |
| Grant Gordon | M | 62 |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 26 years |
| Larry G. Badgley | M | 67 | 16 years | |
| Robert W. Schleizer | M | - |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 10 years |
| Leigh M. McAlister | M | 74 |
The University of Texas at Austin
| 38 years |
| Donna Luedtke | F | - | - | |
| Richard M. Sepulvado | M | - | 19 years | |
| Jason R. Gorsuch | M | - | 11 years | |
| James L. Merkel | M | - | - | |
| James R. Richards | M | - |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 10 years |
| Alfred C. Moran | M | - |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 10 years |
| Jonathan Sessler | M | 68 |
The University of Texas at Austin
| 40 years |
| David Ornitz | M | - |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rizalyn R. Cabrillas | F | 42 | - | |
| Thomas Patrick Schaeffer | M | 72 | 2 years | |
| Donald E. Moss | M | 79 |
The University of Texas at Austin
| 10 years |
| Daniel C. Montano | M | 75 |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 16 years |
| John William Jacobs | M | 74 |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 14 years |
| Mickael Flaa | M | 71 |
Venturis Therapeutics, Inc.
Venturis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Venturis Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease and peripheral artery disease. The company develops injectable and topical formulations of its active pharmacological ingredient to facilitate the growth of new blood vessels in the heart, tissues and organs. It focuses on developing protein drug candidates to be used in the treatment of cardiovascular disease. CardioVascular BioTherapeutics was founded by Daniel C. Montano, Thomas J. Stegmann and Grant Gordon in March 1998 and is headquartered in Dallas, TX. | 16 years |
| David White | M | - |
The University of Texas at Austin
| 6 years |
| Allen H. Kupetz | M | - |
The University of Texas at Austin
| 3 years |
| Crystal S. Coranes | F | 40 | - | |
| David Brown | M | 61 | 6 years | |
| Phyllis K. Harding | F | 78 | 3 years | |
| DAVID S. Peterman | M | - |
The University of Texas at Austin
| 7 years |
| Julie Kramer Gerron | F | 56 |
The University of Texas School of Law
The University of Texas at Austin
| 7 years |
| Ken Shibusawa | M | 63 |
The University of Texas at Austin
| 7 years |
| Duane King | M | 63 |
The University of Texas at Austin
| 7 years |
| Mel S. Carter | M | - |
The University of Texas at Austin
| 7 years |
| Michael Weinberg | M | - |
The University of Texas at Austin
| 8 years |
| Robert Carter Overton | M | - |
The University of Texas at Austin
| 6 years |
| Rex W. Canon | M | 63 |
The University of Texas at Austin
| 7 years |
| David Lamar Hallman | M | - |
The University of Texas at Austin
| 6 years |
| Brad Vaughn | M | - |
The University of Texas at Austin
| 7 years |
| Diana Walters | F | 60 |
The University of Texas at Austin
| 5 years |
| Tom Wilkinson | M | 55 |
The University of Texas at Austin
| 6 years |
| Jorge Sorokin | M | - |
The University of Texas at Austin
| 5 years |
| Sudhir Joshi | M | - |
The University of Texas at Austin
| 3 years |
| Fiur Kevin | M | - |
The University of Texas School of Law
The University of Texas at Austin
| 7 years |
| John Ghiselli | M | 60 |
The University of Texas at Austin
| 6 years |
| Thomas J. Murphy | M | - |
The University of Texas at Austin
| 5 years |
| David Ryan Druley | M | - |
The University of Texas at Austin
| 18 years |
| H. Hays Lindsley | M | 65 |
The University of Texas at Austin
| 7 years |
| Stanley Bould | M | - |
The University of Texas at Austin
| 7 years |
| Belinda Johnson | F | 57 |
The University of Texas School of Law
The University of Texas at Austin
| 7 years |
| Jim Long | M | - |
The University of Texas at Austin
| 7 years |
| Brian D. Baird | M | 60 |
The University of Texas at Austin
| 7 years |
| H. Lee Matthews | M | - |
The University of Texas at Austin
| 7 years |
| W. Lance Schuler | M | - |
The University of Texas at Austin
| 7 years |
| Marilou Moursund | F | - |
The University of Texas at Austin
| 5 years |
| Audrey T. Andrews | F | 57 |
The University of Texas at Austin
| 6 years |
| Buddie Cloys Ballard | M | - |
The University of Texas at Austin
| 4 years |
| Lance J. Rosmarin | M | 59 |
The University of Texas at Austin
| 7 years |
| Bryan Willson | M | - |
The University of Texas at Austin
| - |
| William Lockhart Garwood | M | 67 |
The University of Texas at Austin
| 6 years |
| Barrett Rouse | M | - |
The University of Texas at Austin
| 6 years |
| Brian L. Gerber | M | - |
The University of Texas at Austin
| 6 years |
| Russell Kampfe | M | - |
The University of Texas at Austin
| 4 years |
| Mario Yzaguirre | M | 63 |
The University of Texas School of Law
The University of Texas at Austin
| 7 years |
| Franklin Ruben | M | - |
The University of Texas at Austin
| 7 years |
| Alan D. Green | M | 59 |
The University of Texas at Austin
| 4 years |
| Nelson Haight | M | 59 |
The University of Texas at Austin
| 5 years |
| Susanne Gealy | F | - |
The University of Texas at Austin
| 5 years |
| Gerard Arpey | M | 65 |
The University of Texas at Austin
| 6 years |
| Larry Lee Sears | M | 69 | 2 years | |
| Michael T. Segrest | M | - |
The University of Texas at Austin
| 6 years |
| Thomas Fallon | M | 62 |
The University of Texas at Austin
| 7 years |
| Daniel Rabinovitsj | M | 59 |
The University of Texas at Austin
| 7 years |
| Thomas D. Williams | M | 63 |
The University of Texas at Austin
| 6 years |
| David E. Schwartz | M | - |
The University of Texas at Austin
| 7 years |
| Eric Reehl | M | 63 |
The University of Texas at Austin
| 5 years |
| Gene C. Howard | M | 97 | - | |
| Bob Clements | M | 81 | - | |
| Lisa Stephens | F | - |
The University of Texas at Austin
| 5 years |
| Richard K. Hoesterey | M | 81 | 2 years | |
| Jim Sherwin | M | - |
The University of Texas at Austin
| 6 years |
| Robert I. Newton | M | 58 |
The University of Texas School of Law
The University of Texas at Austin
| 7 years |
| Alex Stephen Trevino | M | 61 |
The University of Texas at Austin
| 6 years |
| Paul R. Ferretti | M | 76 | - | |
| Gabriela Franco Parcella | F | 55 |
The University of Texas at Austin
| 5 years |
| Ralph A. Wagner | M | - |
The University of Texas at Austin
| 7 years |
| Robert L. Hargett | M | - |
The University of Texas at Austin
| 7 years |
| Jeff Lucado | M | - |
The University of Texas at Austin
| 6 years |
| Noreen Skelly | F | 59 |
The University of Texas at Austin
| 4 years |
| Matthew Townsend Strong | M | - |
The University of Texas at Austin
| 4 years |
| Glennis Dixon | F | - |
The University of Texas at Austin
| 4 years |
| Eric K. Tutterow | M | - |
The University of Texas at Austin
| 1 years |
| David Myers | M | - |
The University of Texas at Austin
| 4 years |
| Jill Lampert | F | 58 |
The University of Texas at Austin
| 4 years |
| Lyndall Thomas Baker | M | - |
The University of Texas at Austin
| 3 years |
| Julien Smythe | M | - |
The University of Texas at Austin
| 4 years |
| Carl Allen Robinson | M | - |
The University of Texas at Austin
| 4 years |
| Mary Thompson | F | 61 |
The University of Texas at Austin
| 4 years |
| Ananth Dodabalapur | M | - |
The University of Texas at Austin
| 1 years |
| William Wayne Colston | M | 56 |
The University of Texas at Austin
| 4 years |
| Christine A. Hathaway | F | - |
The University of Texas at Austin
| 4 years |
| Hendi Prio Santoso | M | 57 |
The University of Texas at Austin
| 2 years |
| Brad K. Broyhill | M | - |
The University of Texas at Austin
| 4 years |
| Stephen C. Jumper | M | 62 |
The University of Texas at Austin
| 4 years |
| Robert Epstein | M | 59 |
The University of Texas at Austin
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jon Stuart Ross
- Personal Network
